“THE INTEGRATION AND USE OF CANCER BIOMARKERS IN THE DECISION MAKING PROCESSES IN CLINICAL DEVELOPME

来源 :2007年生物芯片与疾病分子分型国际研讨会(International Symposium on Biochip Tec | 被引量 : 0次 | 上传用户:eyx001
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Academia and biomedical industry are using new genomic technologies to develop biomarkers for cancer molecular classification and prediction of treatment responsiveness and clinical outcome.Such marke
会议
会议
Antibodies are important tools for investigating the proteome,but current methods for producing them have become a rate-limiting step in proteomic studies.A primary obstacle in most methods for genera
会议
To investigate the expression difference of microRNAs between the invasive and non-invasive pituitary adenomas and their association with the development of these two kinds of tumors,eight cases of no
会议
会议
会议
会议
会议